Onconomics Plus™：
A Circulating
Tumour Cell Test
Onconomics Plus
Standard treatment protocols are built from what tends to work across many patients with a similar diagnosis.
That’s valuable information — but it’s still an average.
Your cancer cells are not an average. They’re yours.
Think of it like being handed a key without knowing what lock it opens. It might fit. It might not — and there’s no way to know for certain in advance.
Onconomics Plus is a circulating tumour cell test — a liquid biopsy where a blood sample is taken to study your circulating tumour cells (CTCs). In certain cases, a tissue sample may also be used.
What Exactly Is Onconomics Plus
How your cancer cells respond when exposed to a range of conventional anti-cancer drugs
Gene expression profiling — information about the biological activity of your cancer cells
Onconomics Plus does not replace your treatment decisions or serve as a diagnostic test — it is considered alongside them, providing additional biological information that your medical team may consider alongside other clinical information.
Why "It Depends on Your Biology"
Is Not a Dead End
Same Size. Different Feet.
Same cancer type
Same stage
Similar test results
Two patients can have the same cancer type, the same stage, and even similar test results — yet still respond completely differently to the same treatment.
Think of it like two people who wear the same shoe size but don’t have the same feet. The shoe size tells you where to start — it doesn’t guarantee the fit.
Your Own Cells
A closer look at your specific biology, gathered directly from your own circulating tumour cells.
Beyond the Group Average
More specific biological information for your medical team — not just population data.
The test investigates three areas:
Conventional Anti-Cancer Drugs
Natural Substances
Gene Expression Profiling
What a Result Might Actually Look Like – to make this more concrete, a report from Onconomics Plus might show, for example:
Why Would That Matter to You?
How Oritov Supports Your Understanding
A report full of biological terminology is not useful on its own — it needs to be understood, discussed, and placed into context. Oritov provides education to help bridge that gap.
We Help You Understand What the Report Shows
We provide education on what Onconomics Plus measures and what the resulting report may mean — for both patients and medical teams.
Education grounded in the test’s actual methodology — to help you ask better questions and have more informed conversations with your medical team.
Supporting Your Medical Team
This is a specialised and evolving area of testing — and one that Oritov helps both patients and medical teams navigate.
We provide education on how to understand and discuss these findings within the context of your overall care.
Getting Started Is
Simpler Than You Think
Talk to Us
Tell us about your situation.
We will help you understand whether this circulating tumour cell test may be relevant to you and answer general questions about the process.
We Support Your Doctor Conversation
We provide educational resources about the testing pathway that you can share with your doctor — supporting a more informed discussion between you and your medical team.
We Handle the Coordination
Oritov coordinates the referral with a registered partner clinic in Singapore.
You focus on your health — we handle the rest.
A Simple Blood Draw
A blood sample is collected at a registered clinic by a qualified medical professional.
That is all that is needed from you.
Your Medical Team Receives the Report
Your laboratory report goes directly to your medical team.
Oritov provides educational support to help you and your doctor understand the biological information — so your next care discussion with your medical team is better informed, with greater clarity.
CONTINUE EXPLORING
Continue Your Journey
Could This Circulating Tumour Cell Test Be Relevant to Your Situation?
The next question is whether this information is relevant to the treatment decisions ahead of you.
FREQUENTLY ASKED QUESTIONS
What does Onconomics Plus™ actually test?
Onconomics Plus™ examines your own circulating tumour cells for three things: how they respond to a range of conventional anti-cancer drugs, how they respond to certain natural substances, and gene expression profiling — information about their biological activity.
How much does Onconomics Plus™ cost, and is it covered by insurance?
Cost varies depending on your specific situation and the sample type required. This is something we discuss directly with you during your first conversation with our team, so you have clear information before deciding whether to proceed. Coverage depends on your individual insurance policy or plan — we recommend checking with your provider directly, and we can help point you toward the right questions to ask them.
Does this replace my medical team’s treatment plan?
No. This test provides additional biological information that your medical team may consider alongside other clinical information — it does not determine your treatment on its own. Clinical decisions remain with your doctors. Results from this test are not used for diagnosis or health screening.
Why hasn’t my doctor mentioned this test?
This is a specialised and evolving area of testing. Oritov exists to bridge this gap — providing education for both patients and medical teams on what the test measures and how this information may support more informed care discussions.
What happens when I speak with your team?
We start by understanding your situation and what you have already discussed with your medical team. We then walk you through what Onconomics Plus measures, what a report may show, and how the referral pathway works if it’s relevant to you. There is no obligation — the goal is to help you leave with clarity, not a sales pitch.
